Tolerability of SGLT2 inhibitors in patients with Fabry disease: An observational study. [PDF]
Am Heart J PlusMattig I +7 more
europepmc +1 more source
Sacubitril/valsartan fails to prevent doxorubicin-induced cognitive impairment and hippocampal oxidative, inflammatory, and apoptotic alterations in rats. [PDF]
Front PharmacolAlresheedi MM, Aldubayan MA.
europepmc +1 more source
Angiotensin receptor-neprilysin inhibitor treatment in people with chronic obstructive pulmonary disease and heart failure. [PDF]
Commun Med (Lond)Hsu WH +10 more
europepmc +1 more source
Evaluating the effects of sacubitril/valsartan with ST-elevated myocardial infarction: a systematic review and meta-analysis. [PDF]
Ann Med Surg (Lond)Kumar A +10 more
europepmc +1 more source
C3 mutation-associated atypical hemolytic uremic syndrome with severe renal dysfunction and hypertensive emergency successfully treated with ravulizumab and sacubitril/valsartan: a case report. [PDF]
BMC NephrolYanagidani H +9 more
europepmc +1 more source
Aromaticity-driven laser photo-responses and binding efficiency in IAF-conjugated natural products for neurodegenerative disease targets. [PDF]
Signal Transduct Target TherNik Zulkarnine NH +2 more
europepmc +1 more source
Beyond circulating cGMP: revisiting compartmentalized signaling in HFrEF. [PDF]
Int J Cardiol Heart VascPütz R +6 more
europepmc +1 more source
Fulfilling the Promise of Cyclic GMP Signaling in Heart Failure With Reduced Ejection Fraction. [PDF]
JACC Heart FailReddy YNV.
europepmc +1 more source